David Mountcastle - Nov 5, 2021 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Nov 5, 2021
Transactions value $
-$768,931
Form type
4
Date filed
11/9/2021, 05:07 PM
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Sale -$746K -27.3K -35.94% $27.37 48.6K Nov 5, 2021 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Sale -$22.4K -801 -1.65% $28.02 47.8K Nov 5, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.96 to $27.95 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.97 to $28.06 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.